Synthonics

Synthonics

Biotechnology, 2200 Kraft Dr Ste 2225, Blacksburg, Virginia, 24060, United States, 1-10 Employees

synthonicsinc.com

  • twitter
  • LinkedIn

phone no Phone Number: 54********

Who is SYNTHONICS

Synthonics, Inc. is a privately-held specialty pharmaceutical company focused on the discovery and development of patentable drugs that incorporate our proprietary metal coordination chem...

Read More

map
  • 2200 Kraft Dr Ste 2225, Blacksburg, Virginia, 24060, United States Headquarters: 2200 Kraft Dr Ste 2225, Blacksburg, Virginia, 24060, United States
  • 2006 Date Founded: 2006
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from SYNTHONICS

Synthonics Org Chart and Mapping

VP-Level
Employees

Michaela Mulhare

Lab Manager/Research Scientist

John Tinkham

CEO, Former General Counsel and Business Dev Director

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Synthonics

Answer: Synthonics's headquarters are located at 2200 Kraft Dr Ste 2225, Blacksburg, Virginia, 24060, United States

Answer: Synthonics's phone number is 54********

Answer: Synthonics's official website is https://synthonicsinc.com

Answer: Synthonics's revenue is $1 Million to $5 Million

Answer: Synthonics's SIC: 2834

Answer: Synthonics's NAICS: 325412

Answer: Synthonics has 1-10 employees

Answer: Synthonics is in Biotechnology

Answer: Synthonics contact info: Phone number: 54******** Website: https://synthonicsinc.com

Answer: Synthonics, Inc. is a privately-held specialty pharmaceutical company focused on the discovery and development of patentable drugs that incorporate our proprietary metal coordination chemistry. We bind metals to known pharmaceutical agents to create new products that are better absorbed and thus have greater therapeutic benefits than their predecessors. Although our chemistry has broad application, we're preliminarily focused on drugs, such as T3 (liothyronine) and levodopa, whose short half-life limits their clinical utility. S

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access